Cargando…
Risk of liver disease in methotrexate treated patients
Methotrexate is the first line drug treatment for a number of rheumatic and non-rheumatic diseases. It is effective in controlling disease activity and preventing disease-related damage, and significantly cheaper than many alternatives. Use in rheumatoid arthritis infers a significant morbidity and...
Autores principales: | Conway, Richard, Carey, John J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612840/ https://www.ncbi.nlm.nih.gov/pubmed/28989565 http://dx.doi.org/10.4254/wjh.v9.i26.1092 |
Ejemplares similares
-
Developing natural marine products for treating liver diseases
por: Wei, Qian, et al.
Publicado: (2022) -
Risk of Infection with Methotrexate Therapy in Inflammatory Diseases: A Systematic Review and Meta-Analysis
por: Ibrahim, Ammar, et al.
Publicado: (2018) -
Non-alcoholic fatty liver disease and cardiovascular risk
por: Patil, Rashmee, et al.
Publicado: (2017) -
Pharmacogenetic studies of thiopurine methyltransferase genotype‐phenotype concordance and effect of methotrexate on thiopurine metabolism
por: Zimdahl Kahlin, Anna, et al.
Publicado: (2020) -
Liver and COVID-19: From care of patients with liver diseases to liver injury
por: Gaspar, Rui, et al.
Publicado: (2021)